BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20135058)

  • 1. Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes.
    Vismara E; Pierini M; Mascellani G; Liverani L; Lima M; Guerrini M; Torri G
    Thromb Haemost; 2010 Mar; 103(3):613-22. PubMed ID: 20135058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity.
    Achour O; Bridiau N; Godhbani A; Le Joubioux F; Bordenave Juchereau S; Sannier F; Piot JM; Fruitier Arnaudin I; Maugard T
    Carbohydr Polym; 2013 Sep; 97(2):684-9. PubMed ID: 23911501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of *OH initiated by interaction of Fe2+ and Cu+ with dioxygen; comparison with the Fenton chemistry.
    Urbański NK; Beresewicz A
    Acta Biochim Pol; 2000; 47(4):951-62. PubMed ID: 11996118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modification induced in heparin by a Fenton-type depolymerization process.
    Vismara E; Pierini M; Guglieri S; Liverani L; Mascellani G; Torri G
    Semin Thromb Hemost; 2007 Jul; 33(5):466-77. PubMed ID: 17629843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation.
    Bisio A; De Ambrosi L; Gonella S; Guerrini M; Guglieri S; Maggia G; Torri G
    Arzneimittelforschung; 2001 Oct; 51(10):806-13. PubMed ID: 11715633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical destruction of MTBE using Fenton's reagent: effect of ferrous iron/hydrogen peroxide ratio.
    Burbano A; Dionysiou D; Suidan M; Richardson T
    Water Sci Technol; 2003; 47(9):165-71. PubMed ID: 12830956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.
    Eriksson BI; Söderberg K; Widlund L; Wandeli B; Tengborn L; Risberg B
    Thromb Haemost; 1995 Mar; 73(3):398-401. PubMed ID: 7667822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of the chronometric assays to determine plasma antifactor Xa activity during low molecular weight heparin therapy.
    Boneu B; Faruel-Bille V; Pierrejean D; Gabaig AM
    Nouv Rev Fr Hematol (1978); 1991; 33(4):287-91. PubMed ID: 1664095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radical generation during chemical depolymerization of heparin.
    Rota C; Liverani L; Spelta F; Mascellani G; Tomasi A; Iannone A; Vismara E
    Anal Biochem; 2005 Sep; 344(2):193-203. PubMed ID: 16098471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of transition metal ions on iron-dependent lipid peroxidation.
    Repetto MG; Ferrarotti NF; Boveris A
    Arch Toxicol; 2010 Apr; 84(4):255-62. PubMed ID: 19936709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins.
    Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2002 Aug; 28(4):355-60. PubMed ID: 12244482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of dyes in aqueous solutions by the Fenton process.
    Xu XR; Li HB; Wang WH; Gu JD
    Chemosphere; 2004 Nov; 57(7):595-600. PubMed ID: 15488921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of low molecular weight heparins.
    Bara L; Samama M
    Acta Chir Scand Suppl; 1990; 556():57-61. PubMed ID: 1963018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of low molecular weight heparin using an ultrasound-assisted Fenton-system.
    Zhi Z; Li J; Chen J; Li S; Cheng H; Liu D; Ye X; Linhardt RJ; Chen S
    Ultrason Sonochem; 2019 Apr; 52():184-192. PubMed ID: 30559077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced oxidation processes: mechanistic aspects.
    von Sonntag C
    Water Sci Technol; 2008; 58(5):1015-21. PubMed ID: 18824799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the reaction pathway of OH radicals produced by Fenton oxidation in the conditions of wastewater treatment.
    Yoon J; Lee Y; Kim S
    Water Sci Technol; 2001; 44(5):15-21. PubMed ID: 11695453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions.
    Barrowcliffe TW; Le Shirley Y
    Thromb Haemost; 1989 Nov; 62(3):950-4. PubMed ID: 2556814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fe-exchanged zeolite as the effective heterogeneous Fenton-type catalyst for the organic pollutant minimization: UV irradiation assistance.
    Kusić H; Koprivanac N; Selanec I
    Chemosphere; 2006 Sep; 65(1):65-73. PubMed ID: 16600328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns.
    Sissi C; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2003 Dec; 29(6):661-70. PubMed ID: 14719183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.